The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis
The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Benjamin M Koerber, PhD
- Phone Number: 8147909364
- Email: benk@icarusmedical.com
Study Contact Backup
- Name: Evan Eckersley
- Phone Number: (570) 955-9662
- Email: evan@icarusmedical.com
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22902
- Icarus Medical Innovations
-
Contact:
- Ben Koerber
- Phone Number: 8147909364
- Email: koerberbm1@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults aged 30-70, as significant knee OA is very common for people under 30, and would be more likely correlated to trauma.
- Able to ambulate with or without assistive devices
- Body-mass index (BMI) under 35. This is to minimize the effect of the variable of how the brace fits on the patient. The finding of pain relief will extrapolate to any BMI.
- Willingness and ability to comply with scheduled visits and study procedures
- Willingness and ability to fill out patient questionnaires written in English
- Ability to provide informed consent
- Clinical diagnosis of medial or lateral compartment knee osteoarthritis requiring a KO.
- Subject is suitable for unilateral bracing
Exclusion Criteria:
- Significant cognitive impairment interfering with study assessments
- Active infections or wounds at the foot or leg
- Severe spasticity that limits brace fitting or functioning
- History of severe lower limb deformities that would preclude brace use
- History of major joint surgery or joint implants, such as total knee replacement
- Other neurological or musculoskeletal conditions unrelated to the lower limbs that significantly impact gait
- Non-ambulatory
- Inability to travel for study procedures or fill out required surveys
- Medical conditions of interest
- Pregnant women
- Prisoners
- Clinical diagnosis of knee osteoarthritis that is not specific to the knee's medial or lateral compartment (multicompartmental, or patellofemoral knee osteoarthritis)
- Self-reported pain score of less than 3 out of 10 in the medial compartment.
- Varus or valgus deformity greater than 12°
- Inability to read/write/communicate in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis
Patients experiencing unicompartment (medial or lateral) osteoarthritis will receive Icarus Adonis Joint Distraction brace. Patients will wear the brace for 12 weeks and document how often they wear the brace and their pain scores. Patients will fill out outcome surveys at 2, 4, 6, 8, and 12 weeks. |
Patients will receive Icarus Adonis Joint Distraction brace. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: Baseline, 2, 4, 8, 12 weeks
|
Scored 0 to 100, where 0 represents total knee disability and 100 represents perfect knee |
Baseline, 2, 4, 8, 12 weeks
|
|
European Quality of Life-5 Dimensions (EQ-5D-5L)
Time Frame: Baseline, 2, 4, 8, 12 weeks.
|
0 to 1, where 1 is perfect health |
Baseline, 2, 4, 8, 12 weeks.
|
|
Visual Analogue Scale (VAS)
Time Frame: Baseline, 2, 4, 8, 12 weeks.
|
0-100, zero meaning no pain, 10 meaning severe pain |
Baseline, 2, 4, 8, 12 weeks.
|
|
Functional Mobility Assessments
Time Frame: Baseline, 2, 4, 8, 12 weeks
|
6 minute walk test |
Baseline, 2, 4, 8, 12 weeks
|
|
Functional Mobility Assessment
Time Frame: Baseline, 2, 4, 8, 12 weeks
|
5 times Sit to Stand test |
Baseline, 2, 4, 8, 12 weeks
|
|
Functional Mobility Assessment
Time Frame: Baseline, 2, 4, 8, 12 weeks
|
Timed Up and Go test |
Baseline, 2, 4, 8, 12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003 Nov 3;1:64. doi: 10.1186/1477-7525-1-64.
- Boonstra AM, Schiphorst Preuper HR, Reneman MF, Posthumus JB, Stewart RE. Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. Int J Rehabil Res. 2008 Jun;31(2):165-9. doi: 10.1097/MRR.0b013e3282fc0f93.
- Losina E, Paltiel AD, Weinstein AM, Yelin E, Hunter DJ, Chen SP, Klara K, Suter LG, Solomon DH, Burbine SA, Walensky RP, Katz JN. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res (Hoboken). 2015 Feb;67(2):203-15. doi: 10.1002/acr.22412.
- Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014 Jul 18;5(3):351-61. doi: 10.5312/wjo.v5.i3.351. eCollection 2014 Jul 18.
- Cherian JJ, Bhave A, Kapadia BH, Starr R, McElroy MJ, Mont MA. Strength and Functional Improvement Using Pneumatic Brace with Extension Assist for End-Stage Knee Osteoarthritis: A Prospective, Randomized trial. J Arthroplasty. 2015 May;30(5):747-53. doi: 10.1016/j.arth.2014.11.036. Epub 2014 Nov 29.
- Parween R, Shriram D, Mohan RE, Lee YHD, Subburaj K. Methods for evaluating effects of unloader knee braces on joint health: a review. Biomed Eng Lett. 2019 Jan 23;9(2):153-168. doi: 10.1007/s13534-019-00094-z. eCollection 2019 May.
- Heinemann AW, Bode RK, O'Reilly C. Development and measurement properties of the Orthotics and Prosthetics Users' Survey (OPUS): a comprehensive set of clinical outcome instruments. Prosthet Orthot Int. 2003 Dec;27(3):191-206. doi: 10.1080/03093640308726682.
- Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, Lin J, Guo A. Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022 Jul;74(7):1172-1183. doi: 10.1002/art.42089. Epub 2022 Jun 2.
- Devlin N, Roudijk B, Ludwig K, editors. Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide [Internet]. Cham (CH): Springer; 2022. No abstract available. Available from http://www.ncbi.nlm.nih.gov/books/NBK589304/
- Jm B, Pw S, Sa L. Lower Extremity Functional Scale (LEFS).
- Nori SL, Stretanski MF. Foot Drop. In: StatPearls. StatPearls Publishing; 2024. Accessed September 24, 2024. http://www.ncbi.nlm.nih.gov/books/NBK554393/
- Ciolino JD, Kaizer AM, Bonner LB. Guidance on interim analysis methods in clinical trials. J Clin Transl Sci. 2023 May 15;7(1):e124. doi: 10.1017/cts.2023.552. eCollection 2023.
- Stetter BJ, Fiedler J, Arndt M, Stein T, Sell S. Impact of a Semi-Rigid Knee Orthotic Intervention on Pain, Physical Activity, and Functional Capacity in Patients with Medial Knee Osteoarthritis. J Clin Med. 2024 Mar 7;13(6):1535. doi: 10.3390/jcm13061535.
- Wilder FV, Barrett JP Jr. The association between medication usage and dropout status among participants of an exercise study for people with osteoarthritis. Phys Ther. 2005 Feb;85(2):142-9.
- Balkman GS, Bamer AM, Stevens PM, Weber EL, Morgan SJ, Salem R, Amtmann D, Hafner BJ. Development and initial validation of the Orthotic Patient-Reported Outcomes-Mobility (OPRO-M): An item bank for evaluating mobility of people who use lower-limb orthoses. PLoS One. 2023 Nov 2;18(11):e0293848. doi: 10.1371/journal.pone.0293848. eCollection 2023.
- Paluska SA, McKeag DB. Knee braces: current evidence and clinical recommendations for their use. Am Fam Physician. 2000 Jan 15;61(2):411-8, 423-4.
- DeRogatis M, Anis HK, Sodhi N, Ehiorobo JO, Chughtai M, Bhave A, Mont MA. Non-operative treatment options for knee osteoarthritis. Ann Transl Med. 2019 Oct;7(Suppl 7):S245. doi: 10.21037/atm.2019.06.68.
- McCormack DJ, Puttock D, Godsiff SP. Medial compartment osteoarthritis of the knee: a review of surgical options. EFORT Open Rev. 2021 Feb 1;6(2):113-117. doi: 10.1302/2058-5241.6.200102. eCollection 2021 Feb.
- Perdisa F, Bordini B, Salerno M, Traina F, Zaffagnini S, Filardo G. Total Knee Arthroplasty (TKA): When Do the Risks of TKA Overcome the Benefits? Double Risk of Failure in Patients up to 65 Years Old. Cartilage. 2023 Sep;14(3):305-311. doi: 10.1177/19476035231164733. Epub 2023 Apr 19.
- Franklin PD, Suleiman L, Ibrahim SA. Racial/Ethnic and Sex Differences in Total Knee Arthroplasty Outcomes. JAMA Netw Open. 2020 May 1;3(5):e205000. doi: 10.1001/jamanetworkopen.2020.5000. No abstract available.
- Wang MC, Chan PH, Paxton EW, Bellows J, Koplan K, Rabrenovich V, Convissar J, Reddy NC, Grimsrud CD, Navarro RA. Factors Influencing Patient Satisfaction With Care and Surgical Outcomes for Total Hip and Knee Replacement. Perm J. 2021 Nov 3;25:21.043. doi: 10.7812/TPP/21.043.
- Goodman SM, Mehta B, Zhang M, Szymonifka J, Nguyen JT, Lee L, Figgie MP, Parks ML, Dey SA, Crego D, Russell LA, Mandl LA, Bass AR. Disparities in Total Hip Arthroplasty Outcomes: Census Tract Data Show Interactions Between Race and Community Deprivation. J Am Acad Orthop Surg. 2018 Nov 1;26(21):e457-e464. doi: 10.5435/JAAOS-D-17-00393.
- Chun DS, Leonard AK, Enchill Z, Suleiman LI. Racial Disparities in Total Joint Arthroplasty. Curr Rev Musculoskelet Med. 2021 Dec;14(6):434-440. doi: 10.1007/s12178-021-09718-3. Epub 2021 Oct 9.
- Ezomo OT, Sun D, Gronbeck C, Harrington MA, Halawi MJ. Where Do We Stand Today on Racial and Ethnic Health Disparities? An Analysis of Primary Total Hip Arthroplasty From a 2011-2017 National Database. Arthroplast Today. 2020 Nov 2;6(4):872-876. doi: 10.1016/j.artd.2020.10.002. eCollection 2020 Dec.
- Segal NA. Bracing and orthoses: a review of efficacy and mechanical effects for tibiofemoral osteoarthritis. PM R. 2012 May;4(5 Suppl):S89-96. doi: 10.1016/j.pmrj.2012.01.018.
- Alam M, Choudhury IA, Bin Mamat A. Mechanism and design analysis of articulated ankle foot orthoses for drop-foot. ScientificWorldJournal. 2014;2014:867869. doi: 10.1155/2014/867869. Epub 2014 Apr 30.
- Kobayashi E, Hiratsuka K, Haruna H, Kojima N, Himuro N. Efficacy of Knee-Ankle-Foot Orthosis on Functional Mobility and Activities of Daily Living in Patients with Stroke: A Systematic Review of Case Reports. J Rehabil Med. 2022 Jul 7;54:jrm00290. doi: 10.2340/jrm.v54.87.
- Bashir AZ, Dinkel DM, Pipinos II, Johanning JM, Myers SA. Patient Compliance With Wearing Lower Limb Assistive Devices: A Scoping Review. J Manipulative Physiol Ther. 2022 Feb;45(2):114-126. doi: 10.1016/j.jmpt.2022.04.003. Epub 2022 Jun 24.
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 303260
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD must be deidentified according to UVA IRB standard. If this would be the case then we would plan to share IPD and publish this study.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.